| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Glycosphingolipid biosynthesis . lacto and neolacto series |
4 genes: FUT9, FUT4, ST8SIA1, B3GALT2
|
0.001431 |
| Long.term potentiation |
6 genes: ADCY1, GRIN2A, PPP1R12A, PLCB4, PPP1CB, PRKCB
|
0.002245 |
| Calcium signaling pathway |
10 genes: ADCY1, ERBB4, GRIN2A, SLC25A4, PDE1C, PLCB4, PRKCB, PTGER3, RYR2, SLC8A1
|
0.002284 |
| Phosphatidylinositol signaling system |
5 genes: INPP5A, PIK3C2A, PLCB4, PRKCB, PIP4K2B
|
0.01712 |
| Inositol phosphate metabolism |
4 genes: INPP5A, PIK3C2A, PLCB4, PIP4K2B
|
0.02379 |
| Vascular smooth muscle contraction |
6 genes: CALCRL, ADCY1, PPP1R12A, PLCB4, PPP1CB, PRKCB
|
0.02453 |
| ErbB signaling pathway |
5 genes: ERBB4, PAK3, PRKCB, SOS1, STAT5B
|
0.0261 |
| Glycosphingolipid biosynthesis . globo series |
2 genes: FUT9, ST8SIA1
|
0.02873 |
| Chemokine signaling pathway |
8 genes: ADCY1, GNG7, PLCB4, GNG2, PRKCB, CXCL12, SOS1, STAT5B
|
0.02993 |
| Glycosphingolipid biosynthesis . ganglio series |
2 genes: ST6GALNAC3, ST8SIA1
|
0.03274 |
| Ras signaling pathway |
9 genes: KDR, SOS1, GNG2, GNG7, GRIN2A, PAK3, FOXO4, KSR2, PRKCB
|
0.03918 |
| GnRH signaling pathway |
5 genes: ADCY1, MAP3K3, PLCB4, PRKCB, SOS1
|
0.04521 |
| Pancreatic secretion |
5 genes: ADCY1, PLCB4, PRKCB, RYR2, SLC4A4
|
0.04521 |
| Cell adhesion molecules .CAMs. |
6 genes: CADM1, NEGR1, NCAM1, NCAM2, NRXN3, NRXN1
|
0.04755 |
| Fatty acid metabolism |
3 genes: ADH1B, ACADSB, ACOX1
|
0.04928 |